Prevention of non-melanoma skin cancer.
Basal cell and squamous cell carcinomas comprise the majority of non-melanoma skin cancers. Whereas the incidence of skin cancer is equivalent to that of all other cancers combined, non-melanoma skin cancer receives a disproportionate share of attention because mortality is relatively low. However, the impact on public health is striking. This review is intended to update readers on the current findings in research on the prevention of these diseases. Topics covered include preventive strategies targeting high-risk populations, chemoprevention (including treatment of intraepithelial neoplasia), and an overview of recent and ongoing clinical and preclinical studies involving new chemopreventive agents.
Stratton
S P
SP
Section of Hematology and Oncology, Arizona Cancer Center, College of Medicine, University of Arizona, Tucson, AZ 85724, USA. stratton@azcc.arizona.edu
D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D002278:Carcinoma in Situ / Q000628:therapy*; D002280:Basal Cell Carcinoma / Q000517:prevention & control*; D002294:Carcinoma, Squamous Cell / Q000517:prevention & control*; D018890:Chemoprevention; D002986:Clinical Trials as Topic; D006801:Humans; D015994:Incidence; D011230:Precancerous Conditions; D012307:Risk Factors; D012878:Skin Neoplasms / Q000517:prevention & control*
D016588:Anticarcinogenic Agents